Triamcinolone

CHEMBL1451 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
394.4 g/mol
LogP
1.2
Phase
4

This corticosteroid medication reduces inflammation and immune activity and is used to treat a wide range of conditions including asthma, allergic reactions, skin conditions like eczema and psoriasis, and joint inflammation from arthritis. It is available in multiple forms including inhalers, skin creams, nasal sprays, and injections directly into joints or lesions. Long-term or widespread use can cause side effects including thinning skin, elevated blood sugar, and adrenal suppression.

Khối lượng phân tử

394,4000 g/mol

LogP

1,20

TPSA

115,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F

InChI

InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1

Molecular Formula

C21H27FO6

HBD / HBA

4 / 7

Liên kết có thể quay

2

Nguyên tử nặng

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This corticosteroid medication reduces inflammation and immune activity and is used to treat a wide range of conditions including asthma, allergic reactions, skin conditions like eczema and psoriasis, and joint inflammation from arthritis. It is available in multiple forms including inhalers, skin creams, nasal sprays, and injections directly into joints or lesions. Long-term or widespread use can cause side effects including thinning skin, elevated blood sugar, and adrenal suppression.

Yes, Triamcinolone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1451. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 31307. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.